{"id":149,"date":"2025-06-04T08:39:01","date_gmt":"2025-06-04T08:39:01","guid":{"rendered":"https:\/\/alhenascience.com\/aim\/publications\/"},"modified":"2025-06-04T14:02:07","modified_gmt":"2025-06-04T14:02:07","slug":"publications","status":"publish","type":"page","link":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"<ol>\n<li>Successful preclinical proof-of-concept study of a CAR-T cell approach targeting CD84 to treat acute myeloid leukemia. Hum Gene Ther 2025;36:e165.<\/li>\n<li>Preclinical development of a CAR-T cell approach targeting the CD84 antigen associated to pediatric acute myeloid leukemia. Blood 2022;140(Suppl 1):10247-10248.<\/li>\n<li>CD72 is a pan-tumor antigen associated with childhood acute leukemia. Blood 2022;140(Suppl 1):4974-4975.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Successful preclinical proof-of-concept study of a CAR-T cell approach targeting CD84 to treat acute myeloid leukemia. Hum Gene Ther 2025;36:e165. Preclinical development of a CAR-T cell approach targeting the CD84 antigen associated to pediatric acute myeloid leukemia. Blood 2022;140(Suppl 1):10247-10248. CD72 is a pan-tumor antigen associated with childhood acute leukemia. Blood 2022;140(Suppl 1):4974-4975.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":143,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-149","page","type-page","status-publish"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Publications - Alhena Science<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alhenascience.com\/it\/our-technology\/publications\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications - Alhena Science\" \/>\n<meta property=\"og:description\" content=\"Successful preclinical proof-of-concept study of a CAR-T cell approach targeting CD84 to treat acute myeloid leukemia. Hum Gene Ther 2025;36:e165. Preclinical development of a CAR-T cell approach targeting the CD84 antigen associated to pediatric acute myeloid leukemia. Blood 2022;140(Suppl 1):10247-10248. CD72 is a pan-tumor antigen associated with childhood acute leukemia. Blood 2022;140(Suppl 1):4974-4975.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alhenascience.com\/it\/our-technology\/publications\/\" \/>\n<meta property=\"og:site_name\" content=\"Alhena Science\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T14:02:07+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/it\\\/our-technology\\\/publications\\\/\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/it\\\/our-technology\\\/publications\\\/\",\"name\":\"Publications - Alhena Science\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#website\"},\"datePublished\":\"2025-06-04T08:39:01+00:00\",\"dateModified\":\"2025-06-04T14:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/it\\\/our-technology\\\/publications\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/alhenascience.com\\\/it\\\/our-technology\\\/publications\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/it\\\/our-technology\\\/publications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/alhenascience.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Technology\",\"item\":\"https:\\\/\\\/alhenascience.com\\\/our-technology\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Publications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#website\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/\",\"name\":\"Alhena Science\",\"description\":\"Towards curative medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/alhenascience.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#organization\",\"name\":\"Alhena Science\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/alhenascience.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-alhena-01.png\",\"contentUrl\":\"https:\\\/\\\/alhenascience.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-alhena-01.png\",\"width\":267,\"height\":266,\"caption\":\"Alhena Science\"},\"image\":{\"@id\":\"https:\\\/\\\/alhenascience.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Publications - Alhena Science","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/","og_locale":"it_IT","og_type":"article","og_title":"Publications - Alhena Science","og_description":"Successful preclinical proof-of-concept study of a CAR-T cell approach targeting CD84 to treat acute myeloid leukemia. Hum Gene Ther 2025;36:e165. Preclinical development of a CAR-T cell approach targeting the CD84 antigen associated to pediatric acute myeloid leukemia. Blood 2022;140(Suppl 1):10247-10248. CD72 is a pan-tumor antigen associated with childhood acute leukemia. Blood 2022;140(Suppl 1):4974-4975.","og_url":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/","og_site_name":"Alhena Science","article_modified_time":"2025-06-04T14:02:07+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/","url":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/","name":"Publications - Alhena Science","isPartOf":{"@id":"https:\/\/alhenascience.com\/#website"},"datePublished":"2025-06-04T08:39:01+00:00","dateModified":"2025-06-04T14:02:07+00:00","breadcrumb":{"@id":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alhenascience.com\/it\/our-technology\/publications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/alhenascience.com\/it\/our-technology\/publications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/alhenascience.com\/"},{"@type":"ListItem","position":2,"name":"Our Technology","item":"https:\/\/alhenascience.com\/our-technology\/"},{"@type":"ListItem","position":3,"name":"Publications"}]},{"@type":"WebSite","@id":"https:\/\/alhenascience.com\/#website","url":"https:\/\/alhenascience.com\/","name":"Alhena Science","description":"Towards curative medicine","publisher":{"@id":"https:\/\/alhenascience.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alhenascience.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/alhenascience.com\/#organization","name":"Alhena Science","url":"https:\/\/alhenascience.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/alhenascience.com\/#\/schema\/logo\/image\/","url":"https:\/\/alhenascience.com\/wp-content\/uploads\/2025\/05\/logo-alhena-01.png","contentUrl":"https:\/\/alhenascience.com\/wp-content\/uploads\/2025\/05\/logo-alhena-01.png","width":267,"height":266,"caption":"Alhena Science"},"image":{"@id":"https:\/\/alhenascience.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/comments?post=149"}],"version-history":[{"count":1,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/149\/revisions"}],"predecessor-version":[{"id":150,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/149\/revisions\/150"}],"up":[{"embeddable":true,"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/pages\/143"}],"wp:attachment":[{"href":"https:\/\/alhenascience.com\/it\/wp-json\/wp\/v2\/media?parent=149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}